Design of a dissolution system for the evaluation of the release rate characteristics of artemether and dihydroartemisinin from tablets

International Journal of Pharmaceutics

Volumn 274, Issue 1-2, 2004, Pages 245-260

  Gabriels M ^a   Plaizier Vercammen, J ^a  

^a PHARMACEUTICAL INSTITUTE   (Belgium)

Author keywords

Artemether; Dihydroartemisinin; Two phase partition dissolution

Indexed keywords

ARTEMETHER; ARTEMETHER PLUS BENFLUMETOL; BUTANE; COTECXIN; DIHYDROARTEMISININ; METHANOL; OCTANE; ORGANIC SOLVENT;

ANALYTIC METHOD; AQUEOUS SOLUTION; ARTICLE; CALCULATION; DENSITY; DRUG RELEASE; DRUG SCREENING; DRUG SOLUBILITY; EVAPORATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; TABLET FORMULATION;

EID: 1842505247     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2004.01.022     Document Type: Article

References (19)

1. Aiache J.M., Blume H., Fuedel D.H., Grady L.T., Gray V., Hubert B. FIP guidelines for dissolution testing of solid oral products (final draft 1995). Drug Inform. J. 30:1996;1055-1061.
2. Bhattachar S.N., Wesley J.A., Fioritto, Martin P.J., Babu S.R. Dissolution testing of a poorly soluble compound using the flow-through cell dissolution apparatus. Int. J. Pharm. 236:2002;135-143.
3. EMEA, 1999a. Note for guidance specifications: test procedures and acceptance criteria for new drug substances and new drug products: chemical substances, on quality of modified release products. A: oral dosage forms; B: transdermal dosage forms, section I (quality), CPMP/ICH/367/96, pp. 1-15.
4. EMEA, 1999b. Note for guidance specifications: Guidance on quality of modified release products: A: oral dosage forms; B: transdermal dosage forms, section I (quality), CPMP/ICH/604/96, pp. 1-15.
5. EMEA, 2001. Note for guidance on the investigation of bioavailability and bioequivalence, CPMP/BWP/QWP/1401/98, pp. 1-19.
6. Green M.D., Mount D.L., Wutz R.A. Authentication of artemether, artesunate and dihydroartemisinin antimalarial tablets using a simple colorimetric method. Trop. Med. Int. Health. 6:2001;980-982.
7. Hoa N.T., Kinget R. Design and evaluation of two-phase partition-dissolution method and its use in evaluating artemisinin tablets. J. Pharm. Sci. 85:1996;1060-1063.
8. Hoa N.T., Michoel A., Kinget R. Dissolution of arternisinin solid oral dosage forms. Int. J. Pharm. 138:1996;185-190.
9. Newton P., Proux S., Green M., Smithuis F., Rozendaal J., Prakongpan S., Chotivanich K., Mayxay M., Looareesuwan S., Farrar J., Nosten F., White N.J. Fake artesunate in southeast Asia. Lancet. 357:2001;1948-1950.
10. Posti J., Speiser P. Sink conditions in the flow-through cell during dissolution. Int. J. Pharm. 5:1980;101-107.
11. Qureshi S.A. The USP dissolution apparatus suitability test. Drug Inform. J. 30:1996;1055-1061.
12. Rozendaal J. Fake antimalaria drugs in Cambodia. Lancet. 357:2001;890.
13. Shah V.P., Konceny J.J., Everett L.L., McCullough B., Noorizadeh A.C., Skelly J.P. In vitro dissolution profile of water-insoluble drug dosage forms in the presence of surfactants. Pharm. Res. 6:1989;612-618.
14. Taylor R.B., Shakoor O., Behrens R.H., Everard M., Low A.S., Wangboonskul J., Reid R.G., Kolawole J.A. Pharmacopoeial quality of drugs supplied by Nigerian pharmacies. Lancet. 357:2001;1933-1936.
15. Thomas C.G., Ward S.A., Edwards G. Selective determination in plasma of artemether and its metabolite dihydroartemisinin by high-performance liquid chromatography with ultraviolet detection. J. Chromatogr. 583:1992;131-136.
16. U.S. Department of Health and Human Services (FDA-CDER), 1997. Guidance for industry. Dissolution of Immediate Release Solid Oral Dosage Forms. Document Rockville, MD 20 857, BP1, Office of Training and Communications (Fishers Lane, USA), pp. 1-11 ( www.fda.govlcder/guidance.htm ).
17. SM) 24 & The National Formulary 19, Rockville (USA).
18. White N.J., Nosten F., Looareesuwan S., Watkins W.M., Marsh K., Snow R.W., Kokwaro G., Ouma J., Hien T.T., Molyneux M.E., Taylor T.E., Newbold C.I., Ruebush T.K. II, Danis M., Greenwoud B.M., Anderson R.M., Olliaro P. Averting a malaria disaster. Lancet. 353:1999;1965-1967.
19. Zhao S.-S., Zeng M.-Y. Spektrophotometrische Hoch-druck Flüssigkeits-chromatographische (HPLC) Untersuchungen zur Analytik von Qinghaosu. Planta Medica. 1985:1985;233-237.